PLEXIGLAS® News

Evonik has established joint venture in South Africa for production of extruded PLEXIGLAS®

Essen, Germany, August 22, 2012
  • Joint venture with Ampaglas Plastics Group in South Africa

  • Production of extruded PLEXIGLAS® sheets 
     

On May 1 Evonik Industries established a joint venture, Evonik Acrylics Africa (EAA), with the South African plastics processor Ampaglas Plastics Group for extrusion of PLEXIGLAS® sheet products. The new company is headquartered in Elandsfontein, Johannesburg.

“In Ampaglas, we've succeeded in winning over southern Africa's largest producer of extruded plastics as a partner,” says Gregor Hetzke, head of Evonik's Performance Polymers Business Unit. “Our aim in doing so is to further consolidate our good market position through local production in attractive growth regions.”

The goal of the joint venture, in which Evonik holds a 51 percent stake, is the production of high-quality PLEXIGLAS® sheeting and its marketing, particularly in the growth markets of the African continent. The focus here lies on the building and architecture market segments, the design-oriented lighting technologies segment, and furniture, shopfitting, and exhibition booth construction.

Contact

Doris Hirsch

PR-Management Acrylic Polymers

  • Evonik Industries is a worldwide manufacturer of PMMA products sold under the PLEXIGLAS® trademark on the European, Asian, African and Australian continents and under the trademark ACRYLITE® in the Americas.

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (adjusted EBITDA) of about €2.8 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.